1 / 6

FDA’s Regulatory Development Timeline

FDA’s Regulatory Development Timeline. Until Aug. 30, 2002 : Will seek input on stakeholder concerns and suggested options to consider in developing the notice of proposed rulemaking (NPRM) Dec. 2002 - Anticipated: Issue NPRMs for all four regulations with public comment period.

aquarius
Télécharger la présentation

FDA’s Regulatory Development Timeline

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. FDA’s Regulatory Development Timeline • Until Aug. 30, 2002: Will seek input on stakeholder concerns and suggested options to consider in developing the notice of proposed rulemaking (NPRM) • Dec. 2002 - Anticipated: Issue NPRMs for all four regulations with public comment period

  2. FDA’s Regulatory Development Timeline • After NPRM published: Receive/review public comments; we also anticipate holding several public meetings to explain NPRM and seek feedback • No later than Nov. 12, 2003: Issue final rules* *APA requires 30 days notice before effective date

  3. Some Key Personnel in BT Regulatory Development Effort • CFSAN Decision Maker: L. Robert Lake • CFSAN Overall Lead: Leslye M. Fraser • Outreach: Linda A. Skladany, OC, External Affairs

  4. CFSAN Day-to-Day Workgroup Leads • Administrative Detention – Marquita Steadman • Registration – Leslye M. Fraser • Records (Traceback) – Nega Beru • Prior Notice – Mary Ayling

  5. Where to Send Your Comments • Written comments: • Dockets Management Branch (HFA-305) Food and Drug Administration5630 Fishers Lane, rm. 1061Rockville, MD 20852 • Electronic comments:http://www.fda.gov/dockets/ecomments

  6. Where to Send Your Comments (cont) • Please include applicable docket number: • Sec. 303 (Detention): Docket 02N-0275 • Sec. 305 (Registration): Docket 02N-0276 • Sec. 306 (Recordkeeping): Docket 02N-0277 • Sec. 307 (Prior Notice): Docket 02N-0278

More Related